跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
hepatitis B virus therapy
首页
药物
hepatitis B virus therapy
hepatitis B virus therapy
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PHARMACEUTICAL COMBINATION OF A THERAPEUTIC OLIGONUCLEOTIDE TARGETING HBV AND A TLR7 AGONIST FOR TREATMENT OF HBV
US 2023119360 A1
申请人: HOFFMANN LA ROCHE
优先权: 2019
CN
EP
US
WO
4 件公开
COMBINATION THERAPY FOR TREATING HEPATITIS B VIRUS INFECTIONS
EP 4469161 A1
申请人: GLAXOSMITHKLINE IP DEV LTD
优先权: 2022
CN
EP
US
WO
4 件公开
ASSESSMENT AND TREATMENT OF CHRONIC HEPATITIS B
EP 4731254 A2
申请人: BRII BIOSCIENCES INC
优先权: 2023
CN
EP
US
WO
4 件公开
MEGANUCLEASE VARIANTS CLEAVING THE GENOME OF A PATHOGENIC NON-INTEGRATING VIRUS AND USES THEREOF
US 2012171191 A1
申请人: CHOULIKA ANDRE
优先权: 2009
EP
US
WO
4 件公开
RNAi Therapy for Hepatitis B Virus Infection
US 10130651 B2
申请人: ARROWHEAD PHARMACEUTICALS INC
优先权: 2015
CN
US
4 件公开
Nucleosides with anti-hepatitis B virus activity
US 7468357 B2
申请人: UNIV EMORY
优先权: 2001
US
4 件公开
HCV peptide compositions
US 2005202418 A1
申请人: HOUGHTON MICHAEL
优先权: 2002
US
4 件公开
Drug for treating hemophilia and method of treating hemophilia using the same
US 2006240114 A1
申请人: UEDA MASAKAZU
优先权: 2003
CN
EP
US
3 件公开
VIRAL GENE THERAPY VECTOR FOR REMOVING HEPATITIS B VIRUSES AND USE
EP 4796641 A1
申请人: GUANGZHOU CHASER BIOTECHNOLOGY CO LTD
优先权: 2023
CN
EP
WO
3 件公开
Beta-L-N4-Hydroxycytosine Deoxynucleosides and their use as Pharmaceutical Agents in the Prophylaxis or Therapy of Viral Diseases
US 2009105186 A1
申请人: MAX DELBRUECK CENTRUM
优先权: 2004
CN
US
3 件公开
第 1 / 6 页
上一页
下一页
药物
反馈